Kaustuv K. Sahoo, Ph.D.
Affiliations: | 2014 | Pharmacy | University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States |
Area:
Pharmacy, Oncology, Cell BiologyGoogle:
"Kaustuv Sahoo"Parents
Sign in to add mentor| Vibhudutta Awasthi | grad student | 2014 | University of Oklahoma Health Sciences Center | |
| (Preclinical investigations on CLEFMA for lung cancer therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Perumal V, Sivakumar PM, Zarrabi A, et al. (2019) Near infra-red polymeric nanoparticle based optical imaging in Cancer diagnosis. Journal of Photochemistry and Photobiology. B, Biology. 199: 111630 |
| Sahoo K, Karumuri S, Hikkaduwa Koralege RS, et al. (2017) Molecular and biocompatibility characterization of red blood cell membrane targeted and cell penetrating peptide-modified polymeric nanoparticles. Molecular Pharmaceutics |
| Yadav VR, Hussain A, Sahoo K, et al. (2014) Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA. The Journal of Pharmacology and Experimental Therapeutics. 351: 413-22 |
| Yadav VR, Sahoo K, Awasthi V. (2013) Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft. British Journal of Pharmacology. 170: 1436-48 |
| Yadav VR, Sahoo K, Roberts PR, et al. (2013) Pharmacologic suppression of inflammation by a diphenyldifluoroketone, EF24, in a rat model of fixed-volume hemorrhage improves survival. The Journal of Pharmacology and Experimental Therapeutics. 347: 346-56 |
| Yadav VR, Sahoo K, Awasthi V. (2013) Abstract 4866: CLEFMA induces apoptosis and downregulates inflammatory markers in lung cancer model. Cancer Research. 73: 4866-4866 |
| Sahoo KK, Yadav VR, Awasthi V. (2013) Abstract 3286: CLEFMA synergizes with celecoxib in suppression of lung cancer cell growth. Cancer Research. 73: 3286-3286 |
| Lagisetty P, Subramaniam D, Sahoo K, et al. (2012) Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH). Chemical Biology & Drug Design. 79: 194-201 |
| Sahoo K, Dozmorov MG, Anant S, et al. (2012) The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress. Investigational New Drugs. 30: 558-67 |
| Sahoo KK, Yadav VR, Awasthi V. (2012) Abstract 4887: Curcuminoid CLEFMA induces autophagy-associated apoptosis in lung cancer Cancer Research. 72: 4887-4887 |